NEW YORK (AP) — Jailed Wall Street fraudster Bernie Madoff may have finally picked a legitimate winner.
A biopharmaceutical company partly owned by the Madoff family had an initial public offering Tuesday that sold $33 million worth of stock.
The New York Post reports (http://bit.ly/WJWUPi) that Madoff's initial $2.2 million investment in the company, Stemline Therapeutics, is now worth $5.5 million on paper.
But the scammer might not be able to keep the money.
The trustee overseeing efforts to untangle Madoff's Ponzi scheme says the family's shares rightfully belong to his defrauded clients.
He has filed a lawsuit seeking to seize those shares on behalf of fraud victims.
Madoff is expected to spend the rest of his life in prison.
Information from: New York Post, http://www.nypost.com
BUT WE NEED MORE GUN LAWS? Judge Gives Strawman Seller Probation - Bearing Arms - Straw-Purchasing, Wisconsin
How to Write a New York Times Op-Ed in Three Easy Steps | Human Events
Christine Rousselle - Maine Man Who Shot Intruder Robbing Him Told to Give Up His Gun
Don’t rush to judgment on Texas deputies who killed man with hands up - Hot Air
Kim Davis Should Have Done This | RedState
Nick Adams - Not a Single Illegal Immigrant in 7 Months... In Australia
War on cops: Female officer in Penn. assaulted and thrown over guardrail after stopping to help disabled vehicle